Who are Anagin's investors?

Anagin's investors include EcoR1 Capital.

How much funding has Anagin raised?

Anagin has disclosed $4.4M raised across 2 rounds.

Where is Anagin headquartered?

Anagin is headquartered in Indianapolis, US.

Anagin

Indianapolis, US · Founded 2013 · 1 known investors

Anagin develops targeted therapies for neurological and psychiatric diseases caused by disrupted synaptic plasticity, including PTSD, traumatic brain injury, depression, neuropathic pain, Alzheimer's, and Parkinson's disease.

Biotech Digital Health Medical Devices

Founders & leadership

Jaswant GiddaExecutive

James SchulzExecutive

Yvonne LaiNamed on SEC filing

Board

Nora DohertyBoard director

Derek SmallBoard director

Anantha ShekharBoard director

Frank FrenchBoard director

Investors · 1

EcoR1 CapitalSan Francisco

Reported raises · per SEC filings

Form D private placements

$4.4M disclosed across 2 rounds · 2016–2018

▶$1.3MraisedJun 2018 · 20 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Anantha ShekharDirector
Derek SmallDirector
Frank FrenchDirector
Yvonne LaiExecutive Officer
Jaswant GiddaExecutive Officer, Director
James SchulzExecutive Officer
Nora DohertyDirector

Offering amount: $1.4M
Amount sold: $1.3M
First sale: Jun 2018
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$3MraisedApr 2017 · 23 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Nora DohertyDirector
Derek SmallDirector
Yvonne LaiExecutive Officer
Anantha ShekharDirector
Jaswant GiddaExecutive Officer, Director
James SchulzExecutive Officer
Frank FrenchDirector

Offering amount: $3.5M
Amount sold: $3M
First sale: Jun 2016
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Oragenics4 shared keywordsOragenics is a biotech company developing ONP-002, an intranasal neurosteroid drug delivered via a proprietary nasal device to treat the underlying brain injury in concussion patients. The therapy is in clinical development, with Phase 1 complete and Phase 2 trials underway, aiming to address inflammation, oxidative stress, and swelling from brain trauma.

Walgreens4 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.

1Mg4 shared keywordsTata 1mg is India's leading online pharmacy and healthcare platform that offers medicines, lab tests, doctor consultations, and cancer care services. The company operates a digital marketplace serving Indian consumers seeking pharmaceuticals, diagnostic testing, and medical advice.

Companies competing with Anagin for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Anagin do?: Anagin develops targeted therapies for neurological and psychiatric diseases caused by disrupted synaptic plasticity, including PTSD, traumatic brain injury, depression, neuropathic pain, Alzheimer's, and Parkinson's disease.
Who are Anagin's investors?: Anagin's investors include EcoR1 Capital.
How much funding has Anagin raised?: Anagin has disclosed $4.4M raised across 2 rounds.
Where is Anagin headquartered?: Anagin is headquartered in Indianapolis, US.